https://www.personalizedmedicineconference.org/schedule/
November 13 2024
An Evolving Landscape
8:00 a.m.
Registration and Breakfast
8:50 a.m.
President’s Message
SPEAKER | Edward Abrahams, Ph.D., President, Personalized Medicine Coalition
LEARN MORE
9:00 a.m.
Amgen, Personalized Medicine, and the Future of the Pharmaceutical Industry
For nearly two decades, Amgen, a global leader in the pharmaceutical industry, has leaned into the development of innovative personalized medicines that promise big benefits for relatively small patient populations. Executive Vice President David Reese discusses the future of the company and the field.
MODERATOR | Clifton Leaf, former Editor-in-Chief, Fortune magazine
KEYNOTE SPEAKER | David Reese, M.D., Executive Vice President, Chief Technology Officer, Amgen
LEARN MORE
9:30 a.m.
Illumina’s Next Steps and the Future of Personalized Medicine
Illumina, a $23 billion genomic sequencing technology company, has broad-based ambitions for personalized medicine to transform health care across multiple fronts. CEO Jacob Thaysen reveals his vision for the future.
MODERATOR | Clifton Leaf, former Editor-in-Chief, Fortune magazine
KEYNOTE SPEAKER | Jacob Thaysen, Ph.D., CEO, Illumina
LEARN MORE
10:00 a.m.
Networking Break
10:45 a.m.
Investing in Diagnostics
Personalized medicine depends on a strong diagnostics industry, which faces an uncertain future. This panel examines the perspectives of investors and senior executives on the financial future of the industry.
MODERATOR | Michael D. Goldberg, Executive Chairman, DNAnexus, Chairman, CareDx
Brian Caveney, M.D., Chief Medical & Scientific Officer, Labcorp
Michael Pellini, M.D., General Partner, S32
Sam Raha, Chief Operating Officer, Myriad Genetics
Matthew Sykes, Managing Director, Life Sciences and Diagnostics Industry Investments, Goldman Sachs
LEARN MORE
11:30 a.m.
Presentation of the Annual Award for Leadership in Personalized Medicine
The Annual Award for Leadership in Personalized Medicine recognizes an individual whose contributions in science, business, and policy have helped advance the frontiers of the field.
PRESENTER | Brian Munroe, Founder, Board Member, Personalized Medicine Coalition
AWARDEE | Emily Kramer-Golinkoff, Co-Founder, Emily’s Entourage
LEARN MORE
12:00 p.m.
Lunch Break
12:30 p.m.
Sponsored Session/Room 217 | Transforming Standard-of-Care Imaging into Precision Diagnostics
MODERATOR | Ángel Alberich-Bayarri, Ph.D., Founder, CEO, Quibim (session sponsor)
Chiranjiv Singh, Vice President & General Manager, Pixel at Tempus AI
Okan Ekinci, M.D., Chief Medical Information Officer, Roche Information Solutions
Megan Nacar, Vice President of Commercial, DeciBio
1:00 p.m.
Three Decades as Executive, Caregiver, and Philanthropist: Christi Shaw Reflects
Christi Shaw has served as the CEO of a pioneering biopharmaceutical company, as a board member for several life sciences companies, and as a co-founder of the More Moments More Memories Foundation. She also spent a year as a full-time caregiver to her sister. Ms. Shaw reflects on three decades of service to the health care community.
MODERATOR | Kathy Bloomgarden, CEO, Ruder Finn
SPEAKER | Christi Shaw, former CEO, Kite Pharma
LEARN MORE
1:30 p.m.
Personalized Medicine: A Global Endeavor
All countries benefit from the advancement of personalized medicine. National leaders reflect on shared challenges and opportunities.
MODERATOR | Antonio Andreu, M.D., Ph.D., Scientific Director, European Infrastructure for Translational Medicine
Joshua C. Denny, M.D., CEO, All of Us Research Program, U.S. National Institutes of Health
Monika Frenzel, Ph.D., Research Funding and Support Leader, European Partnership for Personalised Medicine; International Coordinator, French National Research Agency
LEARN MORE
2:00 p.m.
Early Detection and the Future of Cancer Care
By detecting molecular cancer signals in the bloodstreams of seemingly healthy patients, a new generation of minimally invasive early cancer detection tests promises to put more patients on the path to personalized cancer treatment, sooner. What might this mean for the future of cancer care? Leading voices discuss.
MODERATOR | Felice Freyer, President, Association of Health Care Journalists
Christina Annunziata, M.D., Ph.D., Senior Vice President, Extramural Discovery Science, American Cancer Society
Tomasz Beer, M.D., Chief Medical Officer, Multi-Cancer Early Detection, Exact Sciences
Bruce Ratner, Author, Early Detection: Catching Cancer When It’s Curable
Sapna Syngal, M.D., M.P.H., Director of Strategic Planning for Prevention and Early Cancer Detection, Dana-Farber Cancer Institute
LEARN MORE
3:00 p.m.
Networking Break
3:45 p.m.
Pediatrics and Personalized Medicine
The era of personalized medicine has brought breakthrough advancements in areas like genomic sequencing and gene therapy. Will this reshape the futures of pediatric patients with rare genetic diseases? Leading voices discuss opportunities and challenges.
MODERATOR | Paul Billings, M.D., Ph.D., Board Member, Xzom
Lillian Garvin, Operations Lead, Center of Precision Medicine, Nicklaus Children’s Hospital
Mira Irons, M.D., Associate Chief, Genetics and Genomics, Boston Children’s Hospital
Julia Vitarello, Mila’s mom, Founder, CEO, Mila’s Miracle Foundation
LEARN MORE
4:30 p.m.
Visions for AI and the Future of Personalized Medicine
Artificial intelligence technologies can query the divergent effects of preventive and treatment interventions across a previously unimaginable range of data points. What might this mean for the future of personalized medicine? Leading voices share visions.
CHAIRPERSON | Joe Franklin, Ph.D., J.D., Special Counsel, Covington & Burling LLP
Ángel Alberich-Bayarri, Ph.D., Founder, CEO, Quibim
Okan Ekinci, M.D., Chief Medical Information Officer, Roche Information Solutions
John Ellithorpe, Ph.D., President, DNAnexus
Jonathan Kish, Ph.D., Head of Research Sciences, Flatiron Health
Kate Sasser, Ph.D., Chief Scientific Officer, Tempus
LEARN MORE
5:30 p.m.
Closing Remarks
SPEAKER | Edward Abrahams, Ph.D., President, Personalized Medicine Coalition
6:00 p.m.
Signature Reception
Museum of Fine Arts
465 Huntington Avenue
Boston, MA 02115
NOVEMBER 14, 2024 PMC
A Systemic Response
8:00 a.m.
Registration and Breakfast
8:55 a.m.
Opening Remarks
SPEAKER | Lincoln Nadauld, M.D., Ph.D., President, CEO, Culmination Bio
9:00 a.m.
PhRMA’s Perspective on United States Public Policies and the Future of Personalized Medicine
As the Chief Medical Officer of the pharmaceutical industry’s leading trade association, Michael Ybarra, an emergency medicine physician, is helping industry executives shape and navigate shifting scientific, economic, and political landscapes in Washington and around the world. Dr. Ybarra shares the pharmaceutical industry’s point-of-view on the status and future of personalized medicine in light of recent public policy changes in the United States.
INTRODUCTION | Cynthia A. Bens, Senior Vice President, Public Policy, Personalized Medicine Coalition
KEYNOTE SPEAKER | Michael Ybarra, M.D., Chief Medical Officer, PhRMA
LEARN MORE
9:30 a.m.
Precision Partnership: Point32Health/GRAIL Discuss Payer Coverage Pilot Program for Multi-Cancer Early Detection Testing
GRAIL and Point32Health are evaluating the impact of blood-based screening tests used to detect cancers before they cause symptoms in a real-world health plan setting. Partner executives reflect on the findings to date.
MODERATOR | Felice Freyer, President, Association of Health Care Journalists
Joshua Ofman, M.D., President, GRAIL
Kate Wallis, Vice President, Clinical Innovation, Point32Health
10:15 a.m.
Networking Break
11:00 a.m.
Clinical Adoption of Personalized Medicine: Opportunities and Challenges
For clinical care providers, personalized medicine may present opportunities to improve care for their patients and make better use of scarce resources by targeting treatments to those most likely to benefit from them. But spearheading the clinical adoption of personalized medicine is anything but easy. Representatives from leading clinical institutions reflect on opportunities and challenges.
MODERATOR | Susanne Munksted, Chief Precision Medicine Officer, Diaceutics
Justin Brueck, System Vice President, Innovation and Research, Endeavor Health
Manoja Lecamwasam, Ph.D., System Vice President, Intellectual Property, Strategic Life Sciences and Device Innovation, CommonSpirit Health
Apostolia M. Tsimberidou, M.D., Ph.D., Professor, Department of Investigational Therapeutics, The University of Texas MD Anderson Cancer Center
LEARN MORE
11:45 a.m.
Introducing a Clinical Adoption Roadmap for Precision Cancer Care
Daryl Pritchard, who serves as the Senior Vice President for Science Policy at the Personalized Medicine Coalition, introduces the Coalition’s new Roadmap for Addressing Clinical Practice Gaps in Precision Cancer Care.
SPEAKER | Daryl Pritchard, Ph.D., Senior Vice President, Science Policy, Personalized Medicine Coalition
LEARN MORE
12:00 p.m.
Personalized Medicine: 20 Years Later
After the first sequencing of a human genome in 2003, officials from the U.S. National Institutes of Health introduced personalized medicine as a “newly created discipline” that promised to “make a profound difference to the health and well-being of all the people of this world.” Pioneering leaders reflect on the past, present, and future of this promise.
MODERATOR | Edward Abrahams, Ph.D., President, Personalized Medicine Coalition
Mark Levin, Partner, Third Rock Ventures
Ralph Snyderman, M.D., Chancellor Emeritus, Duke University
Janet Woodcock, M.D., former Acting Commissioner, U.S. Food and Drug Administration
LEARN MORE
1:00 p.m.
Closing Remarks
SPEAKER | Edward Abrahams, Ph.D., President, Personalized Medicine Coalition
###
FOCR
https://friendsofcancerresearch.org/event/friends-of-cancer-research-annual-meeting-2024/
Friends of Cancer Research (Friends) is proud to host our 17th Annual Meeting. This year’s annual meeting will explore three different topics that focus on approaches for streamlining trial designs and data collection to support efficient regulatory processes and decision-making. Topics presented at the 2024 Annual Meeting will address frequently encountered challenges that can impact the efficiency and conduct of clinical trials, and ultimately, the collection of evidence necessary to support new drug approvals. Please register above and stay tuned for additional updates.
Draft Agenda
10:00 AM: Opening Remarks
10:05 AM: Morning Keynote
Ramsey Baghdadi, Prevision Policy (Moderator)
Robert Califf, U.S. FDA
10:35 AM: Session 1 – Interim Overall Survival Evaluations and Implications for Trial Designs and Analysis Plans
Interim overall survival (OS) data, evaluated alongside early endpoints like progression-free survival and response rate, help assess the risk-benefit profile of new cancer drugs but can be confounded by factors like data maturity and study design features. This session will discuss best practices for trial designs and analysis plans for interim OS analyses in cancer clinical trials as well as the formation of a multistakeholder consortium to conduct simulations, aiming to enhance the accuracy and reliability of interim OS data interpretation. Read the Session 1 White Paper here.
Session 1 Presentation (10 min)
Geoff Oxnard, Eli Lilly and Company
Panel Discussion (40 min)
Keith Flaherty, Mass General Cancer Center (Moderator)
Nicole Gormley, U.S. FDA
David Mitchell, Patient Advocate
Geoff Oxnard, Eli Lilly and Company
Lisa Rodriguez, U.S. FDA
Antony Sabin, GSK
Audience Q&A (10 min)
11:35 AM: Break
11:50 AM: Session 2 – Enhancing Post-Marketing Studies with Pragmatism
Incorporating pragmatic elements into clinical trial designs can enhance the generalizability and efficiency of clinical trials. This session will explore several case studies to inform incorporation of individual pragmatic elements into clinical trials after initial approval to answer specific research questions, enhancing their applicability and efficiency while maintaining regulatory rigor. Read the Session 2 White Paper here.
Session 2 Presentation (10 min)
Paul Kluetz, U.S. FDA
Panel Discussion (40 min)
Richard Schilsky, University of Chicago (Moderator)
Allen Chen, AstraZeneca
Trixia Camacho, Bristol Myers Squibb
Eva May, Patient Advocate
Neal J. Meropol, Flatiron Health
Peter O’Dwyer, University of Pennsylvania
Donna Rivera, U.S. FDA
Audience Q&A (10 min)
12:55 PM: Lunch
1:20 PM: Lunch Keynote
Jeff Allen, Friends of Cancer Research (Moderator)
Kimryn Rathmell, National Cancer Institute
1:50 PM: Session 3 – A Common Strategy for Using ctDNA as an Intermediate Endpoint in Prospectively Designed Trials
Friends has collaborated with various stakeholders to support using change in ctDNA levels as an intermediate endpoint in oncology drug development, demonstrating its association with OS. To standardize ctDNA measurement methodologies, this session will discuss an aligned approach for assessing ctDNA changes, focused on using ctDNA in advanced non-small cell lung cancer (NSCLC) treated with immunotherapy. Read the Session 3 White Paper here.
Session 3 Presentation (10 min)
Hillary Andrews, Friends of Cancer Research
Panel Discussion (40 min)
Charu Aggarwal, Abramson Cancer Center, University of Pennsylvania (Moderator)
Zoe June Assaf, Genentech, A Member of the Roche Group
David Fabrizio, Foundation Medicine, Inc.
Leon Freytor, Johnson & Johnson
Anand Pathak, U.S. FDA
Carol Vallett, Patient Advocate
Paz Vellanki, U.S. FDA
Audience Q&A (10 min)
3:00 PM: Meeting Adjournment
#####
https://milkeninstitute.org/events/future-health-summit-2024
- Welcome Dinners at Ambassador Residences (Invite only)-In celebration of global health, the Milken Institute and diplomatic missions in Washington DC will convene a series of welcome dinners at Ambassador residences as part of the 2024 Milken Institute Fu...
- Continental Breakfast-
- Future of Health Summit Check-in-
- Opening Plenary-
- Part 3: Partnerships Leading to a Healthier Tomorrow-A healthier future cannot be achieved through treatment alone. While care aimed at curing illness or injury is a crucial element of improving health, promoting well-being through prevention is essenti...Watch Session
- Innovation for All: Strategies for Maximizing Impact-Global events have showcased our unprecedented ability to innovate rapidly in biomedical R&D when it is absolutely required. As we move forward, how can we sustain this momentum and tackle major long-...Watch Session
- Decoding Disease: Can Genetics Unlock New Interventions?-As we better understand the genetic architecture of the most complex human diseases, is this knowledge being productively used to produce better interventions? This panel will untangle the debates aro...Watch Session
- The Future of Health Care Financing-
- Part 2: Putting Value into Health Care-Health care financing is a highly complex issue impacting people, systems, and societies. From rising and unsustainable costs to lack of access to high quality care to the needs of an aging population...Watch Session
- Health Policy Insights for the 119th Congress (Invite only)-As we wrap up 2024 and transition into the new Congress, it is critical to understand which health-care priorities are at the forefront of consideration and the opportunities to advance them. Join us ...
- Public Health Advisory Board Meeting (Invite only)-
- Box Lunch Pick-Up-
- Lunch Plenary | Innovations Shaping Health Care-Join us to explore key advancements in health care, looking to highlight innovative mechanisms from revolutionary entities such as the Advanced Projects Agency for Health (ARPA-H) and the next steps f...
- Part 1: Royalty Pharma Prize for Impact in Health Care-Join us for the inaugural Royalty Pharma Prize for Impact in Health Care awarded to Michael Milken.Watch Session
- How Pharmaceutical Supply Chain Advancements Are Meeting the Moment and Beyond-The health-care supply chain has undergone significant transformations driven by evolving health-care demands, technological advancements, and regulatory shifts. Patient-centric approaches, upskilled ...Watch Session
- Food Is Medicine Leaders (Invite only)-This session will explore successes and opportunities for improvement as Food Is Medicine initiatives scale, highlight examples of innovative partnerships for Food Is Medicine implementation, and disc...
- SPARC PLC: The Trust Variable in Science Philanthropy (Invite only)-The buzz around trust-based philanthropy is undeniable, but can it unlock breakthroughs in scientific research? What are the successes and limitations of providing more freedom to scientists and clini...
- Bringing Whole-Person Health to the Workplace-How will future generations change the playbook on mental health in the workplace? Whole-person health approaches have become the gold standard of many classrooms. By teaching students resiliency, cop...Watch Session
- Drafting the Blueprint for the Next Era of Patient Engagement-During the last two decades, the R&D ecosystem has been transformed by a shift to more patient-centric approaches to biomedical R&D. But as the scope and scale of patient engagement expand, efforts to...Watch Session
- Brain Check: Innovations in Prevention, Detection, and Intervention for Neurodegenerative Disease-Brain health is essential for all aspects of daily functioning and healthy aging. Yet, many neurodegenerative and brain-based diseases lack effective treatments or cures and are expected to rise as th...Watch Session
- Global Collaboration to Eradicate Women’s Cancers-The top three women’s cancers globally—breast, cervical and endometrial—affect almost 3.5 million people each year with over 1 million women dying from these diseases. Breast cancer is the most common...Watch Session
- What's Next in Aging: Leveraging Plans and Progress to Meet the Moment-Adults aged 65 and older are the fastest-growing demographic in the workforce and will soon comprise nearly 20 percent of the US population. There is much to celebrate in this growth. Their continued ...Watch Session
- Harnessing Community Power: Driving Health Equity Research-The global events of 2020 amplified health equity discussions, driving urgent calls for system reforms to ensure health justice for all individuals, regardless of socioeconomic status, race, ethnicity...Watch Session
- Protecting Our Youth Online (Invite only)-Between 2011 and 2021, the number of teens and young adults with depression more than doubled. According to the CDC, nearly one in three high school girls reported having seriously considered suicide....
- Advancing Health through Food: Community Health Center Live Innovation Pitch Session and Award (Invite only)-Community health centers see the immense toll that food insecurity has on health for the over 32.5 million people they serve across the US. In this fast-paced, competitive pitch session hosted by the ...
- Unlocking the Policy Agenda for NextGen Biomedical Innovation-Innovation is accelerating in every part of the health-care ecosystem. One direction for such innovation is to improve existing processes and technologies to increase the safety and efficacy of medica...Watch Session
- How Can Clinical Trials Keep Pace with Science?-The speed and precision of medical product research have increased remarkably over time. Genome-informed target identification and automated candidate molecule screening have made the discovery proces...Watch Session
- The Next Frontier in Mental Health Research-Mental illness is one of the most common health conditions—one in every eight people in the world lives with one. The staggering prevalence and impact of these illnesses has prompted worldwide researc...Watch Session
- A Collaborative Network to Advance Women’s Health (Invite only)-Women’s health is underfunded across R&D, products, services, and infrastructure. There is no doubt that women’s health would benefit from cross-sector models to support public and private partnership...
- Welcome Reception-
- Feeding Change Reception (Invite only)-A private reception for Feeding Change guests, stakeholders, and partners. Light refreshments will be served.
- Continental Breakfast-
- Future of Health Summit Check-in-
- Partnering for Patients Networking Breakfast-This networking breakfast is an informal opportunity to connect with leaders in the biomedical, public health, and philanthropy communities. There will be facilitator-led tables discussing a wide rang...
- Designing a Prevention-First Model (Invite only)-Health systems worldwide are exploring opportunities to support their populations in becoming healthier. While rising rates of chronic diseases like obesity and diabetes persist, there is tremendous p...
- Leading with Empathy: Building the Next Generation of Leaders (Invite only)-Employers play an increasingly critical role in public health by the way they treat their employees. A workplace that emphasizes a whole-person approach has the potential to drive greater productivity...
- Why Younger People Are Getting Cancer and What We Can Do About It-For the first time, 2 million Americans will be diagnosed with cancer in 2024. Of those diagnosed, is an alarming increase in early-onset cancer in adults under 45. The trend is now global, occurring ...Watch Session
- Beyond Checkboxes: Elevating Diversity and Representativeness in Patient Engagement-The gold standard for obtaining patient input for biomedical research once was ensuring a representative sample of the population with the disease. Concurrently, in the past several years there has be...Watch Session
- Data Sets That Address All Our Diversity-The Human Genome Project, completed over 20 years ago, heralded the frontier of individualized medicine. Since then, we have developed massive databases and biorepositories that form the critical back...Watch Session
- How Private Equity is Reshaping the Dynamics of Health Care (Invite only)-Private equity investors channeled $151 billion into health care in 2021, up from $79 billion in pre-pandemic 2019. Health care is attractive because of the stability and diversity of the sector, its ...
- Future of Aging Advisory Board Meeting (Invite only)-The Milken Institute Future of Aging Advisory Board brings together influential leaders in a premier forum to accelerate innovation in aging, scale promising solutions, and champion individual, instit...
- Catalysts of Change: Philanthropy, Advocacy, and Innovation in Rare Disease Research-Rare disease patients, advocacy groups, philanthropists, and researchers have overcome significant challenges in their efforts to improve treatment and care. Over the past decade, clinicians have made...Watch Session
- The Price of Health-Medical debt accounts for more than 65 percent of bankruptcies in the US. Crowdsourcing, cash discounts, and price transparency navigators have emerged as ways to help patients pay for their medical b...Watch Session
- Pioneering Technology Transforming Health-
- Part 2: A Glimpse Ahead: The Future of R&D-Scientific and technological innovations will continue to change the lifecycle of drug development, from discovery to clinical trials and commercialization, with the promise to prevent and treat disea...Watch Session
- Feeding Change Business Council Meeting (Invite only)-A private meeting for Feeding Change Business Council members.
- Box Lunch Pick-Up-
- Lunch Plenary-
- Part 2: Bot or Not?: AI in Health Care-The rise of AI has promised transformation across many of our systems, and our health care is no exception. AI is already used to make diagnoses, accelerate therapeutic discovery, catalyze drug develo...Watch Session
- All Hands on Deck: Partnering for Prevention-Preventive measures, including vaccinations, screenings, diagnostics, and prophylaxis, are crucial in helping individuals maintain health and wellness. As populations age and chronic diseases become m...Watch Session
- Resilient Futures: Public-Private Climate Strategies-Increasingly unpredictable environmental conditions are destroying homes, disrupting supply chains, threatening our food supply, and exacerbating health issues across the globe. Climate change impacts...Watch Session
- Connecting the Dots for Women's Health: Research Innovation, Access, and Care-The recent launch of the White House Initiative on Women’s Health and ARPA-H’s Sprint for Women’s Health have brought needed focus on this under-resourced area of health care. As more research is done...Watch Session
- Nourishing the Food and Health Connection-
- Part 2: Food as Engagement: Implications for Health and Access to Care-Food is increasingly being recognized as essential to preventing, managing, and treating chronic diseases. Approximately half of all US adults have at least one preventable diet-related condition, acc...Watch Session
- Building Safer Communities: Public Health Approaches to Gun Violence Prevention-Gun violence is the leading cause of death in children and teens in the US, and for years, it has been referred to as a public health crisis. This panel will discuss what it means to address this plag...Watch Session
- Transforming the Future of Clinical Trials (Invite only)-The COVID-19 pandemic demonstrated that, despite the ultimate success of vaccine development, the US did not have sufficient infrastructure close to communities to run clinical trials effectively, nor...
- Closing Plenary | The Future of Health: What Comes Next-Health remains one of the most critical and foundational elements to leading a meaningful life. Ensuring that everyone has access to the care they want and need, including prevention, treatment, innov...
- Closing Reception-
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.